Manufacturing of Adenovirus Vectors: Production and Purification of Helper Dependent Adenovirus

Methods in Molecular Biology

Volumn 737, Issue , 2011, Pages 139-156

  Dormond, Edwige ^b   Kamen, Amine A ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b NONE

Author keywords

Downstream processing; Gutless adenoviral vectors; Large scale manufacturing; Reactor culture

Indexed keywords

ADENOVIRUS; BIOREACTOR; CELL STRAIN HEK293; CHROMATOGRAPHY; CULTURE TECHNIQUE; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; HELPER VIRUS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; REVIEW; ULTRACENTRIFUGATION; VIRION; WORKFLOW;

ADENOVIRIDAE; BIOREACTORS; CELL CULTURE TECHNIQUES; CHROMATOGRAPHY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HELPER VIRUSES; HUMANS; ULTRACENTRIFUGATION; VIRION; WORKFLOW;

EID: 80052314527     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-095-9_6     Document Type: Chapter

References (21)

1. Altaras NE, Aunins JG, Evans RK, Kamen A, Konz JO, Wolf JJ. (2005) Production and formulation of adenovirus vectors Adv Biochem Eng Biotechnol 99, 193–260.
2. McConnell MJ, Imperiale MJ. (2004) Biology of adenovirus and its use as a vector for gene therapy Hum Gene Ther 15, 1022–33.
3. Tatsis N, Ertl HC. (2004) Adenoviruses as vaccine vectors Mol Ther 10, 616–29.
4. Dormond E, Perrier M, Kamen A. (2009) From the first to the third generation adenoviral vector: what parameters are governing the production yield? Biotechnol Adv 27, 133–44.
5. Graham FL, Smiley J, Russell WC, Nairn R. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5 J Gen Virol 36, 59–74.
6. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML. (1997) Construction of adenovi rus vectors through Cre-lox recombination J Virol 71, 1842–9.
7. Lieber A, He CY, Kirillova I, Kay MA. (1996) Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo J Virol 70, 8944–60.
8. Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, Graham FL. (1996) A helperdependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal Proc Natl Acad Sci USA 93, 13565–70.
9. Ng P, Beauchamp C, Evelegh C, Parks R, Graham FL. (2001) Development of a FLP/ frt system for generating helper-dependent adenoviral vectors Mol Ther 3, 809–15.
10. Umana P, Gerdes CA, Stone D, et al. (2001) Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination Nat Biotechnol 19, 582–5.
11. Oka K, Chan L. (2005) Construction and characterization of helper-dependent adenoviral vectors for sustained in vivo gene therapy Methods Mol Med 108, 329–50.
12. Dormond E, Meneses-Acosta A, Jacob D, et al. (2009) An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection Biotechnol Bioeng 102, 800–10.
13. Kumar-Singh R, Chamberlain JS. (1996) Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells Hum Mol Genet 5, 913–21.
14. Hartigan-O’Connor D, Barjot C, Crawford R, Chamberlain JS. (2002) Efficient rescue of gutted adenovirus genomes allows rapid production of concentrated stocks without negative selection Hum Gene Ther 13, 519–31.
15. Ng P, Parks RJ, Graham FL. (2002) Preparation of helper-dependent adenoviral vectors Methods Mol Med 69, 371–88.
16. Dormond E, Perrier M, Kamen A. (2009) Identification of critical infection parameters to control helper-dependent adenoviral vector production J Biotechnol 142, 142–50.
17. Dormond E, Chahal P, Bernier A, Tran R, Perrier M, Kamen A. (2009) An Efficient Process for the Purification of HelperDependent Adenoviral Vector and Removal of Helper Virus by Iodixanol Ultracentrifugation J Virol Methods (In press).
18. Côté J, Bourget L, Garnier A, Kamen A. (1997) Study of adenovirus production in serum-free 293SF suspension culture by GFPexpression monitoring Biotechnol Prog 13, 709–14.
19. Meneses-Acosta A, Dormond E, Jacob D, et al. (2008) Development of a suspension serum-free helper-dependent adenovirus production system and assessment of co-infection conditions J Virol Methods 148, 106–14.
20. Durocher Y, Perret S, Kamen A. (2002) Highlevel and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells Nucleic Acids Res 30, E9.
21. O’Reilly DR, Miller LK, Luckow VA. Baculovirus Expression Vectors: A Laboratory Manual. New York: Oxford University Press; 1994.